Genomic Health
Top Five Articles on 360Dx Last Week: Fight Brewing Over New FDA LDT Proposal; Medicare Fraud; More
Last week, readers were most interested in a story about another battle brewing over FDA's newest plans for regulating LDTs.
Genomic Health to Pay $32.5M to Resolve Cancer Test False Claims Allegations by DOJ
The settlement includes the resolution of allegations brought in two separate actions filed against the firm under the whistleblower provisions of the False Claims Act.
MDxHealth Acquires Prostate Cancer Testing Business From Exact Sciences for up to $100M
The firm, which also reported preliminary Q2 financial results, acquired the Oncotype DX GPS test along with Exact's urology sales and marketing team.
PreludeDx DCIS Breast Cancer Test Helps Determine Radiation Therapy Benefits, Reduce Overtreatment
Premium
The test uses prognostic markers to group women based on their risk of 10-year recurrence of ductal carcinoma in situ.
Biocartis to Invest in IVD Partnerships Following Termination of Genomic Health Deal
The firm will partner with startup GeneproDx on thyroid cancer diagnostic development, while a separate agreement with Endpoint Health will entail CDx development for critical illness.
May 6, 2020
Exact Sciences Q1 Revenues Up 115 Percent
Feb 12, 2020
Feb 11, 2020
Exact Sciences Q4 Revenues Up 107 Percent
Oct 29, 2019